• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学指导下的软组织肉瘤处理方法。

Histology-Tailored Approach to Soft Tissue Sarcoma.

机构信息

Division of Surgical Oncology, Department of Surgery, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal, QC, Canada.

Division of Orthopedic Oncology, Department of Surgery, Maisonneuve-Rosemont Hospital, Université de Montréal, Montreal, QC, Canada.

出版信息

Ann Surg Oncol. 2024 Nov;31(12):7915-7929. doi: 10.1245/s10434-024-15981-8. Epub 2024 Aug 22.

DOI:10.1245/s10434-024-15981-8
PMID:39174839
Abstract

Soft tissue sarcomas are a diverse and heterogeneous group of cancers of mesenchymal origin. Each histological type of soft tissue sarcoma has unique clinical particularities, which makes them challenging to diagnose and treat. Multidisciplinary management of these rare diseases is thus key for improved survival. The role of surgery has been well established, and it represents the cornerstone curative treatment for soft tissue sarcomas. To date, local recurrence is the leading cause of death in low-grade sarcomas located at critical sites, and distant metastasis in high-grade sarcomas, regardless of the site of origin. Management must be tailored to each individual histologic type. We describe the most common types of extremity, trunk, abdominal, and retroperitoneal soft tissue sarcoma along with characteristics to consider for optimized management.

摘要

软组织肉瘤是一组起源于间充质的异质性和多样化的癌症。每种组织学类型的软组织肉瘤都有其独特的临床特点,这使得它们的诊断和治疗具有挑战性。对这些罕见疾病进行多学科管理对于提高生存率至关重要。手术的作用已经得到充分证实,它是软组织肉瘤的主要治疗方法。迄今为止,局部复发是位于关键部位的低级别肉瘤和远处转移的高级别肉瘤的主要死亡原因,而与起源部位无关。管理必须针对每个个体的组织学类型进行调整。我们描述了最常见的肢体、躯干、腹部和腹膜后软组织肉瘤类型,以及为优化管理而需要考虑的特征。

相似文献

1
Histology-Tailored Approach to Soft Tissue Sarcoma.组织学指导下的软组织肉瘤处理方法。
Ann Surg Oncol. 2024 Nov;31(12):7915-7929. doi: 10.1245/s10434-024-15981-8. Epub 2024 Aug 22.
2
[Surgical therapy of abdominal and trunk soft tissue sarcomas].[腹部及躯干软组织肉瘤的外科治疗]
Chirurg. 2009 Mar;80(3):202-8. doi: 10.1007/s00104-008-1596-5.
3
Soft Tissue Tumors of the Abdomen and Retroperitoneum.腹部和腹膜后软组织肿瘤。
Surg Clin North Am. 2020 Jun;100(3):649-667. doi: 10.1016/j.suc.2020.02.011. Epub 2020 Apr 15.
4
Soft-tissue sarcoma in adults: An update on the current state of histiotype-specific management in an era of personalized medicine.成人软组织肉瘤:在个体化医学时代,组织亚型特异性管理的最新进展。
CA Cancer J Clin. 2020 May;70(3):200-229. doi: 10.3322/caac.21605. Epub 2020 Apr 10.
5
Retroperitoneal Sarcomas: Histology Is Everything.腹膜后肉瘤:组织学就是一切。
Surg Clin North Am. 2022 Aug;102(4):601-614. doi: 10.1016/j.suc.2022.04.004.
6
Sarcomas of soft tissue and bone.软组织和骨骼肉瘤
Cancer. 1991 Aug 1;68(3):463-73. doi: 10.1002/1097-0142(19910801)68:3<463::aid-cncr2820680304>3.0.co;2-e.
7
[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].[1例罕见的伴有横纹肌母细胞分化的神经鞘肉瘤(恶性蝾螈瘤)]
Tumori. 2003 Jul-Aug;89(4 Suppl):246-50.
8
[Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas].[软组织肉瘤多学科治疗中的外科问题]
Praxis (Bern 1994). 1998 Aug 19;87(34):1050-60.
9
The Role of Surgery in Oligometastatic Retroperitoneal Sarcoma.外科手术在寡转移腹膜后肉瘤中的作用。
Curr Oncol. 2023 May 24;30(6):5240-5250. doi: 10.3390/curroncol30060398.
10
Management of localized extremity and retroperitoneal soft tissue sarcoma.局限性肢体和腹膜后软组织肉瘤的治疗管理。
Curr Probl Cancer. 2019 Aug;43(4):273-282. doi: 10.1016/j.currproblcancer.2019.06.002. Epub 2019 Jun 15.

引用本文的文献

1
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).原发性腹膜后肉瘤患者的CINSARC和Sarculator:单机构数据与EORTC-STBSG-62092试验(STRASS)的联合分析
Clin Cancer Res. 2025 Aug 1;31(15):3239-3248. doi: 10.1158/1078-0432.CCR-25-0099.
2
ASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.血管球囊成形术实践指南系列:腹膜后肉瘤的多学科管理
Ann Surg Oncol. 2025 May 9. doi: 10.1245/s10434-025-17284-y.
3
Gene and Cell Therapy for Sarcomas: A Review.

本文引用的文献

1
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group.临床治疗局限性血管肉瘤的推荐意见:意大利肉瘤研究组的共识文件。
Cancer Treat Rev. 2024 May;126:102722. doi: 10.1016/j.ctrv.2024.102722. Epub 2024 Mar 30.
2
Synovial sarcoma: the misdiagnosed sarcoma.滑膜肉瘤:被误诊的肉瘤。
EFORT Open Rev. 2024 Mar 5;9(3):190-201. doi: 10.1530/EOR-23-0193.
3
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
肉瘤的基因与细胞治疗综述
Cancers (Basel). 2025 Mar 27;17(7):1125. doi: 10.3390/cancers17071125.
4
From Data Integration to Precision Medicine: A Value-Based Healthcare Approach for Sarcoma Care.从数据整合到精准医学:一种基于价值的肉瘤护理医疗方法。
J Clin Med. 2024 Oct 30;13(21):6500. doi: 10.3390/jcm13216500.
5
What Is the Prognostic Value of the Pathologic Response after Neoadjuvant Radiotherapy in Soft Tissue Sarcoma? An Institutional Study Using the EORTC-STBSG Response Score.新辅助放疗后软组织肉瘤病理反应的预后价值是什么?一项使用欧洲癌症研究与治疗组织软组织与骨肉瘤组反应评分的机构研究。
Cancers (Basel). 2024 Oct 11;16(20):3449. doi: 10.3390/cancers16203449.
一项新辅助免疫检查点阻断治疗腹膜后去分化脂肪肉瘤和四肢/躯干未分化多形性肉瘤的随机、非对照 2 期研究。
Nat Cancer. 2024 Apr;5(4):625-641. doi: 10.1038/s43018-024-00726-z. Epub 2024 Feb 13.
4
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).高级黏液样脂肪肉瘤的新辅助化疗:意大利(ISG)、西班牙(GEIS)、法国(FSG)和波兰肉瘤组(PSG)扩大随机试验队列的结果。
J Clin Oncol. 2024 Mar 10;42(8):898-906. doi: 10.1200/JCO.23.00908. Epub 2024 Jan 17.
5
Biology and Management of Deep-seated Atypical Lipomatous Tumor of the Extremities.肢体深部非典型性脂肪肿瘤的生物学特性与治疗管理。
Anticancer Res. 2023 Oct;43(10):4295-4301. doi: 10.21873/anticanres.16624.
6
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies.滑膜肉瘤:特征、挑战及不断发展的治疗策略
ESMO Open. 2023 Oct;8(5):101618. doi: 10.1016/j.esmoop.2023.101618. Epub 2023 Aug 23.
7
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall.肢体及躯干壁原发性局限性可切除黏液纤维肉瘤和未分化多形性肉瘤新辅助治疗后的病理和放射学反应。
Cancer. 2023 Nov 1;129(21):3417-3429. doi: 10.1002/cncr.34945. Epub 2023 Jul 15.
8
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2).一项针对高危腹膜后肉瘤患者的新辅助化疗后手术与单纯手术的随机III期研究(STRASS2)。
Ann Surg Oncol. 2023 Aug;30(8):4573-4575. doi: 10.1245/s10434-023-13500-9. Epub 2023 May 11.
9
Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma.未分化多形性肉瘤/肌纤维肉瘤的当前研究与管理
Front Genet. 2023 Feb 16;14:1109491. doi: 10.3389/fgene.2023.1109491. eCollection 2023.
10
Myxoid liposarcoma: a well-defined clinical target variant in radiotherapy for soft tissue sarcoma.黏液样脂肪肉瘤:软组织肉瘤放射治疗中一个明确的临床靶向变体。
Radiat Oncol J. 2022 Dec;40(4):213-215. doi: 10.3857/roj.2022.00598. Epub 2022 Dec 26.